NanoViricides Inc.

NNVCAMEX • USD
ThemeBiotech - Drug Development›Infectious Disease & Vaccines
1.38 USD
↘ 0.12 (8.00%)AT CLOSE (11:59 AM EDT)
1.44
↗ 0.06 (4.35%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
1.44
↗ 0.06 (4.35%)
🔴Market: CLOSED
Open?$1.50
High?$1.54
Low?$1.36
Prev. Close?$1.50
Volume?682.9K
Avg. Volume?1.5M
VWAP?$1.43
Rel. Volume?0.44x
Bid / Ask
Bid?$1.36 × 100
Ask?$1.45 × 500
Spread?$0.09
Midpoint?$1.41
Valuation & Ratios
Market Cap?34.2M
Shares Out?21.6M
Float?21.6M
Float %?100.0%
P/E Ratio?N/A
P/B Ratio?3.73
EPS?-$0.36
Dividend?0.00%
Ex-Dividend?N/A

Shares of NanoViricides Inc. (NNVC) are trading at $1.38. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. NNVC is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
Themes
Biotech - Drug Development›Infectious Disease & VaccinesNanotechnology & Advanced Materials›Nanomedicine & Drug Delivery
Employees
7
Market Cap
34.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.nanoviricides.com
Listed
2005-07-05
Address
1 CONTROLS DRIVE
SHELTON, CT 06484
Phone: (203) 668-5580
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
55
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.34Distress
Confidence?45%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?3.25%Low
Short Interest?702.0K
Days to Cover?1.5
Free Float21.6M
Avg Daily Volume469.3K
Settlement Date2026-05-15
Financial Health
Current Ratio?3.17Strong
Quick Ratio?3.17Strong
Cash Ratio?3.02Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
47
3.73FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-88.4%WEAK▾
ROA?
S&P
3
-79.2%WEAK▾
Cash Flow & Enterprise
FCF?$-7370516
Enterprise Value?$31.0M
Fundamentals ratios updated end of day
MarketsMoversWatchlist